| Application no. and date | 20208220.2 (espacenet) (Federated) (European Patent Register), 20150529 | | Patent/reg. no. and date | DK/EP 3845245, 20250625 | | Publication date | 20210707 | | Priority no. and date | US 201462009474 P, 20140609 | | EP pub. no. and date |
EP 3845245 20210707 | | Effective date | | | Applicant/owner | Ultragenyx Pharmaceutical Inc., 60 Leveroni Court
Novato, CA 94949, US,
Kyowa Kirin Co., Ltd., 1-9-2, Otemachi
Chiyoda-ku
Tokyo 100-0004, JP | | Applicant ref. no. | | | Inventor | KAKKIS, Emil, 546 Biscayne Drive
San Rafael, CA 94901, US,
SAN MARTIN, Javier, c/o Ultragenyx Pharmaceuticals, Inc.
60 Leveroni Court
Novato, CA 94949, US,
SUDO, Tomohiro, 1-6-1
Ohtemachi
Chiyoda-ku, Tokyo 100-8185, JP | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 19/08 (2006.01) , C07K 14/50 (2006.01) , C07K 16/22 (2006.01) | | Title | EFFEKTIV OG VIRKNINGSFULD KONTROL AF SERUMPHOSPHAT TIL OPTIMAL KNOGLEDANNELSE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
